Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience.
Hebraud, Benjamin; Magrangeas, Florence; Cleynen, Alice; Lauwers-Cances, Valerie; Chretien, Marie-Lorraine; Hulin, Cyrille; Leleu, Xavier; Yon, Edwige; Marit, Gerald; Karlin, Lionel; Roussel, Murielle; Stoppa, Anne-Marie; Belhadj, Karim; Voillat, Laurent; Garderet, Laurent; Macro, Margaret; Caillot, Denis; Mohty, Mohamad; Facon, Thierry; Moreau, Philippe; Attal, Michel; Munshi, Nikhil; Corre, Jill; Minvielle, Stephane; Avet-Loiseau, Herve.
; 125(13): 2095-100, 2015 Mar 26.
Artigo em Inglês | MEDLINE | ID: mdl-25636340
Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16).
Biology and therapy of multiple myeloma.
Treatment evolution and improved survival in multiple myeloma in Taiwan.
Multiple myeloma: Every year a new standard?
Progression with clinical features is associated with worse subsequent survival in multiple myeloma.
Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: a retrospective, population based analysis.
Age-related health care disparities in multiple myeloma.
Understanding mortality in multiple myeloma: Findings of a European retrospective chart review.
Clinical impact of the CONUT score in patients with multiple myeloma.
Subclonal <i>TP53</i> copy number is associated with prognosis in multiple myeloma.